GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Liabilities and Shareholders Equity came in at $37.2 billion in Q2 2026, up 4.92% on a YoY basis from $35.5 billion in Q2 2025, and little changed quarter-over-quarter from $37.1 billion in Q1 2026.
Analysis
GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has reported Liabilities and Shareholders Equity for 5 consecutive years, with $37.2 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 4.92% year-over-year to $37.2 billion; the trailing twelve-month figure through Jun 2026 stood at $147.4 billion (up 8.36% YoY), and the FY2025 full-year result was $36.9 billion, up 11.54% from the prior year.
- Liabilities and Shareholders Equity steadied at $37.2 billion in Q2 2026 per GEHC's latest filing, from $37.1 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $37.2 billion in Q2 2026 and bottomed at $27.5 billion in Q4 2022.
- Historically, Liabilities and Shareholders Equity has averaged $33.7 billion across 5 years, with a median of $33.1 billion in 2024.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity rose 17.85% in 2023, then declined 1.42% in 2024.
- Over 5 years, Liabilities and Shareholders Equity stood at $27.5 billion in 2022, then grew by 17.85% to $32.5 billion in 2023, then grew by 1.96% to $33.1 billion in 2024, then advanced by 11.54% to $36.9 billion in 2025, then gained by 0.92% to $37.2 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $37.2 billion, $37.1 billion, and $36.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 37.25 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 2.41 Bn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 344.46 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 3.35 Bn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 283.00 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 5.72 Bn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 166.35 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | 30.24 Mn |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 1.10 Bn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | 153.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.25 Bn |
| Mar 31, 2026 | 37.13 Bn |
| Dec 31, 2025 | 36.91 Bn |
| Sep 30, 2025 | 36.13 Bn |
| Jun 30, 2025 | 35.50 Bn |
| Mar 31, 2025 | 33.59 Bn |
| Dec 31, 2024 | 33.09 Bn |
| Sep 30, 2024 | 33.86 Bn |
| Jun 30, 2024 | 31.85 Bn |
| Mar 31, 2024 | 32.21 Bn |
| Dec 31, 2023 | 32.45 Bn |
| Sep 30, 2023 | 32.38 Bn |
| Jun 30, 2023 | 32.31 Bn |
| Mar 31, 2023 | 32.64 Bn |
| Dec 31, 2022 | 27.54 Bn |